webinar register page

Knight Campus Entrepreneurship Speaker Series with Dr. Carolyn Bertozzi: "Therapeutic Opportunities in Glycoscience"
Carolyn Bertozzi is the Anne T. and Robert M. Bass Professor of Chemistry at Stanford University, an Investigator of the Howard Hughes Medical Institute, and Baker Family Director of Stanford ChEM-H. She is known for developing innovative technologies that open new avenues for biological discovery and therapeutic development. Several of her inventions have been translated to commercial settings. A recent innovation in the design of lysosome targeting chimeras (LYTACs) for targeted degradation of extracellular proteins.

Cell surface glycans constitute a rich biomolecular dataset that drives both normal and pathological processes. Their “readers” are glycan-binding receptors that can engage in cell-cell interactions and cell signaling. Dr. Bertozzi's research focuses on mechanistic studies of glycan/receptor biology and applications of this knowledge to new therapeutic strategies, with recent efforts centering on pathogenic glycans in the tumor microenvironment and new therapeutic modalities based on the concept of targeted degradation.

Apr 27, 2021 10:00 AM in Pacific Time (US and Canada)

* Required information

By registering, I agree to the Privacy Statement and Terms of Service.